X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8488) 8488
Newspaper Article (2612) 2612
Newsletter (509) 509
Magazine Article (159) 159
Trade Publication Article (39) 39
Book Chapter (36) 36
Dissertation (14) 14
Web Resource (13) 13
Report (10) 10
Transcript (10) 10
Reference (6) 6
Book / eBook (5) 5
Book Review (4) 4
Publication (4) 4
Government Document (2) 2
Conference Proceeding (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human papillomavirus (6705) 6705
humans (6247) 6247
female (5255) 5255
vaccines (5003) 5003
cervical cancer (4391) 4391
papillomavirus infections (3347) 3347
papillomavirus infections - prevention & control (3202) 3202
vaccination (3011) 3011
immunization (2932) 2932
papillomavirus vaccines - administration & dosage (2782) 2782
cancer (2716) 2716
adolescent (2711) 2711
adult (2448) 2448
male (1948) 1948
immunology (1928) 1928
uterine cervical neoplasms - prevention & control (1927) 1927
prevention (1757) 1757
health aspects (1577) 1577
young adult (1571) 1571
women (1505) 1505
child (1474) 1474
womens health (1472) 1472
oncology (1264) 1264
middle aged (1245) 1245
research (1225) 1225
hpv (1201) 1201
infection (1186) 1186
uterine cervical neoplasms - virology (1184) 1184
medicine, research & experimental (1151) 1151
public, environmental & occupational health (1073) 1073
animals (1070) 1070
public health (1043) 1043
infectious diseases (1039) 1039
papillomaviruses (1006) 1006
papillomavirus infections - epidemiology (992) 992
cervical-cancer (991) 991
papillomavirus vaccines - immunology (986) 986
medical research (959) 959
infections (946) 946
prevalence (900) 900
papillomavirus infections - virology (887) 887
analysis (874) 874
risk factors (874) 874
health knowledge, attitudes, practice (868) 868
care and treatment (835) 835
vaccine (815) 815
immunotherapy (768) 768
hpv vaccine (765) 765
papillomavirus infections - complications (744) 744
clinical trials (737) 737
united-states (727) 727
mice (716) 716
human-papillomavirus (691) 691
papillomavirus vaccines (682) 682
studies (671) 671
united states (664) 664
cancer vaccines (650) 650
allergy and immunology (633) 633
young-women (629) 629
viruses (626) 626
diagnosis (620) 620
particle vaccine (618) 618
adolescents (615) 615
papillomavirus infections - immunology (614) 614
medicine, experimental (600) 600
medical screening (589) 589
risk (580) 580
epidemiology (572) 572
efficacy (570) 570
medicine (570) 570
uterine cervical neoplasms - epidemiology (568) 568
hpv vaccination (561) 561
antigens (555) 555
papillomavirus vaccines - therapeutic use (555) 555
pediatrics (555) 555
age (544) 544
aged (541) 541
attitudes (540) 540
surveys and questionnaires (539) 539
medicine, general & internal (534) 534
cervix (525) 525
papillomaviridae - immunology (524) 524
immunogenicity (520) 520
human-papillomavirus vaccination (519) 519
pharmaceutical industry (519) 519
teenagers (519) 519
knowledge (513) 513
research article (513) 513
cross-sectional studies (493) 493
sexually transmitted diseases (485) 485
fda approval (480) 480
virus diseases (474) 474
tumors (471) 471
girls (467) 467
proteins (464) 464
abridged index medicus (459) 459
papillomavirus infections - diagnosis (459) 459
uterine cervical neoplasms - diagnosis (456) 456
papillomavirus vaccines - adverse effects (454) 454
obstetrics & gynecology (441) 441
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11702) 11702
French (76) 76
German (55) 55
Spanish (40) 40
Portuguese (32) 32
Swedish (19) 19
Chinese (16) 16
Italian (14) 14
Norwegian (14) 14
Dutch (11) 11
Japanese (11) 11
Danish (10) 10
Polish (7) 7
Russian (7) 7
Czech (3) 3
Bulgarian (2) 2
Hebrew (2) 2
Hungarian (2) 2
Korean (2) 2
Finnish (1) 1
Romanian (1) 1
Serbian (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 100 - 110
Summary Background We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types in the end-of-study analysis after 4 years of follow-up in PATRICIA... 
Hematology, Oncology and Palliative Medicine | IMPACT | ONCOLOGY | PARTICLE VACCINE | NEOPLASIA | RISK | MAJOR CAPSID PROTEIN | IDENTIFICATION | YOUNG-WOMEN | CANCER | HUMAN-PAPILLOMAVIRUS INFECTION | EPITOPES | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adjuvants, Immunologic - administration & dosage | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Precancerous Conditions - diagnosis | Precancerous Conditions - virology | Time Factors | Adult | Female | Papillomavirus Infections - virology | Precancerous Conditions - pathology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Cervical Intraepithelial Neoplasia - virology | Cross Reactions | Antigens, Viral - immunology | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Precancerous Conditions - prevention & control | Australia | Human papillomavirus 16 - genetics | Prevention | Medical colleges | Analysis | Oncology, Experimental | Clinical trials | Cross infection | Vaccines | Nosocomial infections | Research | Papillomavirus infections | Cancer
Journal Article
Virus research, ISSN 0168-1702, 03/2017, Volume 231, pp. 148 - 165
•HPV is a causal factor for multiple cancers and diseases.•Preventative HPV vaccine is not effective at clearing preexisting infections... 
HPV E6 | Human papillomavirus | T cell-based vaccine | Therapeutic vaccine | Immunotherapy | HPV E7 | LISTERIA-MONOCYTOGENES | DENDRITIC CELLS | CANCER | CERVICAL INTRAEPITHELIAL NEOPLASIA | VIROLOGY | IN-VIVO | FUSION PROTEIN | DNA-VACCINE | TYPE-16 E7 | ESTABLISHED TUMORS | ANTITUMOR EFFICACY | Head and Neck Neoplasms - virology | Papillomaviridae - drug effects | Dendritic Cells - immunology | Humans | Vaccination | Vaccines, DNA - immunology | Papillomavirus Vaccines - biosynthesis | Uterine Cervical Neoplasms - pathology | Adoptive Transfer | Vaccines, DNA - administration & dosage | T-Lymphocytes - transplantation | Papillomavirus Infections - pathology | Papillomaviridae - immunology | Immunity, Cellular - drug effects | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Papillomavirus Vaccines - administration & dosage | Head and Neck Neoplasms - prevention & control | Papillomaviridae - growth & development | Cancer Vaccines - administration & dosage | Cancer Vaccines - biosynthesis | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Clinical Trials as Topic | Vaccines, Subunit - immunology | Head and Neck Neoplasms - pathology | Papillomaviridae - pathogenicity | Cancer Vaccines - immunology | Head and Neck Neoplasms - immunology | Vaccines, Subunit - biosynthesis | Papillomavirus Infections - prevention & control | Vaccines, Subunit - administration & dosage | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | T-Lymphocytes - immunology | Vaccines, DNA - biosynthesis | Dendritic Cells - transplantation | Vaccines | T cells | Papillomavirus infections | Health aspects | Prevention | Antigens | Medical research | Microbiology | Medicine, Experimental | therapeutic vaccine | human papillomavirus | immunotherapy
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 5, pp. F123 - F138
Highlights ► The analyses of human papilloma virus/virus-like particle vaccine phase III efficacy trials in young women are largely completed... 
Allergy and Immunology | Prophylactic vaccine | Genital warts | Virus-like particle | Gardasil | Clinical trials | VaIN | CIN | VIN | Cervical cancer | HPV | Cervarix | Vain | Cin | Vin | Hpv | MEDICINE, RESEARCH & EXPERIMENTAL | Cervarix (R) | (HPV)-16/18 AS04-ADJUVANTED VACCINE | OF-STUDY ANALYSIS | Gardasil (R) | CERVICAL-CANCER | IMMUNOLOGY | GRADE 3 | IMMUNOGENICITY | PARTICLE VACCINE | DOUBLE-BLIND | POOLED ANALYSIS | YOUNG-WOMEN | HPV TYPES | Vaccines, Virus-Like Particle - adverse effects | Papillomavirus Infections - complications | Humans | Condylomata Acuminata - virology | Uterine Cervical Neoplasms - prevention & control | Vulvar Neoplasms - virology | Anus Neoplasms - prevention & control | Anus Neoplasms - virology | Male | Vaginal Neoplasms - virology | Condylomata Acuminata - prevention & control | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Clinical Trials, Phase III as Topic | Vaccines, Virus-Like Particle - administration & dosage | Papillomavirus Infections - prevention & control | Vaginal Neoplasms - prevention & control | Vulvar Neoplasms - prevention & control | Papillomavirus Vaccines - adverse effects | Uterine Cervical Neoplasms - virology | Female | Papillomavirus Vaccines - immunology | Vaccines, Virus-Like Particle - immunology | Papillomavirus Vaccines - administration & dosage | Dysplasia | Care and treatment | Oncology, Experimental | Vaccines | Research | Papillomaviruses | Warts | Health aspects | Papillomavirus infections | Public health | Cancer | Human papillomavirus
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 2018, Volume 36, Issue 32, pp. 4774 - 4782
Journal Article
Virus research, ISSN 0168-1702, 2017, Volume 231, pp. 166 - 175
•Licensed (2-, 4-, 9-valent) L1 virus-like particle (VLP) HPV vaccines effectively prevent persistent infection and disease... 
HPV infection and disease | Human papillomavirus (HPV) vaccine | Squamous cell cancer (SCC) | Cutaneous and anogenital warts (condylomata) | Minor capsid protein (L2) | Cervical cancer (CxCa) | L1 PROTEIN | CROSS-NEUTRALIZATION | CELL-SURFACE | MINOR CAPSID PROTEIN | INTRAEPITHELIAL NEOPLASIA | HPV-16/18 AS04-ADJUVANTED VACCINE | IN-VITRO | VIROLOGY | VIRUS-LIKE PARTICLES | COMMON NEUTRALIZATION EPITOPE | IMMUNOGENIC DISPLAY | Immunogenicity, Vaccine | Recombinant Fusion Proteins - immunology | Head and Neck Neoplasms - virology | Oncogene Proteins, Viral - chemistry | Papillomaviridae - drug effects | Humans | Vaccination | Cross Protection | Papillomavirus Vaccines - biosynthesis | Uterine Cervical Neoplasms - pathology | Epitopes - immunology | Papillomavirus Infections - pathology | Papillomaviridae - immunology | Capsid Proteins - chemistry | Vaccines, Virus-Like Particle | Capsid Proteins - immunology | Papillomavirus Infections - immunology | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Papillomavirus Vaccines - administration & dosage | Antibodies, Viral - biosynthesis | Head and Neck Neoplasms - prevention & control | Papillomaviridae - growth & development | Cancer Vaccines - administration & dosage | Cancer Vaccines - biosynthesis | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Vaccines, Subunit - immunology | Recombinant Fusion Proteins - chemistry | Head and Neck Neoplasms - pathology | Papillomaviridae - pathogenicity | Cancer Vaccines - immunology | Head and Neck Neoplasms - immunology | Animals | Vaccines, Subunit - biosynthesis | Antibodies, Neutralizing - biosynthesis | Papillomavirus Infections - prevention & control | Vaccines, Subunit - administration & dosage | Immunity, Humoral - drug effects | Recombinant Fusion Proteins - genetics | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Epitopes - chemistry | Mice | Oncogene Proteins, Viral - immunology | Capsid Proteins - genetics | Prevention | Vaccines | Viral proteins | Health aspects | Papillomavirus infections | Wildlife conservation | Peptides | Development and progression | Papillomaviruses | Warts | Sexually transmitted diseases | Analysis | Skin | Cervical cancer | Antigenic determinants | Human Papillomavirus (HPV) Vaccine | Cervical Cancer (CxCa) | Minor Capsid Protein (L2) | Squamous Cell Cancer (SCC) | cutaneous and anogenital warts (condylomata)
Journal Article
Archives of Virology, ISSN 0304-8608, 3/2018, Volume 163, Issue 3, pp. 587 - 597
To be effective, therapeutic cancer vaccines should stimulate both an effective cell-mediated and a robust cytotoxic CD8... 
Medical Microbiology | Infectious Diseases | Biomedicine | Virology | MODULATORY ROLE | APOPTOSIS | ADVANCED CANCER | VIRUS | VIROLOGY | GROWTH | PROLIFERATION | RECEPTOR AGONIST | COMBINATION | TRANSGENIC MICE | ADJUVANT | Vaccines, DNA - genetics | Adjuvants, Immunologic - administration & dosage | Papillomavirus Vaccines - genetics | Epithelial Cells - drug effects | Tumor Necrosis Factor-alpha - genetics | Vaccination | Papillomavirus E7 Proteins - immunology | Vaccines, DNA - immunology | Human papillomavirus 16 - drug effects | Human papillomavirus 16 - immunology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Vascular Endothelial Growth Factor A - genetics | Vaccines, DNA - administration & dosage | Melatonin - administration & dosage | Papillomavirus E7 Proteins - genetics | Cancer Vaccines - genetics | T-Lymphocytes, Cytotoxic - drug effects | Tumor Necrosis Factor-alpha - immunology | Melatonin - immunology | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Interferon-gamma - genetics | Interleukin-4 - genetics | Papillomavirus Vaccines - administration & dosage | T-Lymphocytes, Cytotoxic - immunology | Cancer Vaccines - administration & dosage | Mice, Inbred C57BL | Plasmids - immunology | Gene Expression Regulation | Vascular Endothelial Growth Factor A - immunology | Papillomavirus Infections - mortality | Tumor Burden | Cancer Vaccines - immunology | Interleukin-4 - immunology | Animals | Lymphocyte Activation - drug effects | Papillomavirus Infections - prevention & control | Epithelial Cells - immunology | Interferon-gamma - immunology | Plasmids - chemistry | Survival Analysis | Cell Line, Tumor | Papillomavirus Vaccines - immunology | Cell Proliferation - drug effects | Mice | Human papillomavirus 16 - genetics | Plasmids - administration & dosage | Melatonin | Endothelial growth factors | Analysis | DNA | Resveratrol | Genetic research | Vaccines | T cells | Health aspects | Papillomavirus infections | Cell proliferation | Cell survival | CD8 antigen | Cytotoxicity | Lymphocytes T | DNA vaccines | Tumor necrosis factor-α | Cancer vaccines | Human papillomavirus | Interleukin 4 | γ-Interferon | Combined vaccines | Interleukin 10 | Antitumor activity | Interferon | Lactic acid | Vascular endothelial growth factor | Enzyme-linked immunosorbent assay | Deoxyribonucleic acid--DNA | Tumors
Journal Article